Clinical efficacy of subgingivally delivered 1.2-mg simvastatin in the treatment of individuals with class II furcation defects: A randomized controlled clinical trial

Journal of Periodontology

Volumn 83, Issue 12, 2012, Pages 1472-1479

  Pradeep, A R ^a   Priyanka, N ^a   Kalra, Nitish ^a   Naik, Savitha B ^a   Singh, Sonender P ^a   Martande, Santosh ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Bone regeneration; Chronic periodontitis; Dental scaling; Root planing; Simvastatin

Indexed keywords

DRUG CARRIER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLCELLULOSE; SIMVASTATIN;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; BONE REGENERATION; CHI SQUARE DISTRIBUTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GEL; HUMAN; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PERIODONTICS; PREVENTIVE DENTISTRY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STENT;

ADULT; ALVEOLAR BONE LOSS; BONE REGENERATION; CHI-SQUARE DISTRIBUTION; DENTAL SCALING; DRUG CARRIERS; FEMALE; GELS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; METHYLCELLULOSE; MIDDLE AGED; PERIODONTAL INDEX; SIMVASTATIN; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; STENTS;

EID: 84871073409     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110716     Document Type: Article

References (36)

1. Shimizu H, Nakagami H, Morita S, et al. New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing. Antioxid Redox Signal 2009;11:2065-2075.
2. Porciúncula HF, da Porciúncula MM, Zuza EP, de Toledo BE. Biometric analysis of the maxillary permanent molar teeth and its relation to furcation involvement. Braz Oral Res 2004;18:187-191.
3. de los Rios CM, Pustiglioni FE, Romito GA. Biometric study of the width, length and depth of the root trunk groove of human lower second molars. Pesqui Odontol Bras 2002;16:26-30.
4. Fleischer HC, Mellonig JT, Brayer WK, Gray JL, Barnett JD. Scaling and root planing efficacy in multirooted teeth. J Periodontol 1989;60:402-409.
5. Kalkwarf KL, Kaldahl WB, Patil KD. Evaluation of furcation region response to periodontal therapy. J Periodontol 1988;59:794-804.
6. Jadhav SB, Jain GK. Statins and osteoporosis: New role for old drugs. J Pharm Pharmacol 2006;58:3-18.
7. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-1949.
8. Stein D, Lee Y, Schmid MJ, et al. Local simvastatin effects on mandibular bone growth and inflammation. J Periodontol 2005;76:1861-1870.
9. Morris MS, Lee Y, Lavin MT, et al. Injectable simvastatin in periodontal defects and alveolar ridges: Pilot studies. J Periodontol 2008;79:1465-1473.
10. Nyan M, Sato D, Oda M, et al. Bone formation with the combination of simvastatin and calcium sulfate in critical-sized rat calvarial defect. J Pharmacol Sci 2007;104:384-386.
11. Sakoda K, Yamamoto M, Negishi Y, Liao JK, Node K, Izumi Y. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res 2006;85:520-523.
12. Takenaka M, Hirade K, Tanabe K, et al. Simvastatin stimulates VEGF release via p44/p42 MAP kinase in vascular smooth muscle cells. Biochem Biophys Res Commun 2003;301:198-203.
13. Pradeep AR, Thorat MS. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial. J Periodontol 2010;81:214-222.
14. Gilding DK, Reed AM. Biodegradable polymers for use in surgery polyglycolic/polylactic acid homo- and copolymers 1. Polymer 1979;2:1459-1484.
15. Al-Kassas RS, El-Khatib MM. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers. Drug Deliv 2009;16:145-152.
16. Ravikumara NR, Madhusudhan B, Nagaraj TS, Hiremat SR, Raina G. Preparation and evaluation of nimesulideloaded ethylcellulose and methylcellulose nanoparticles and microparticles for oral delivery. J Biomater Appl 2009;24:47-64.
17. Final report on the safety assessment of hydroxyethylcellulose, hydroxypropylcellulose, methylcellulose, hydroxypropyl methylcellulose and cellulose gum. Int J Toxicol 1986;5:1-59.
18. Hamp SE, Nyman S, Lindhe J. Periodontal treatment of multirooted teeth. Results after 5 years. J Clin Periodontol 1975;2:126-135.
19. Miller SC. Textbook of Periodontia. Philadelphia: Blakiston Company; 1938:91.
20. Mombelli A, van Oosten MA, Schurch E, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2:145-151.
21. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
22. Francetti L, Trombelli L, Lombardo G, et al. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: A 24-month multicenter study. Int J Periodontics Restorative Dent 2005;25:461-473.
23. Thylin MR, McConnell JC, Schmid MJ, et al. Effects of simvastatin gels on murine calvarial bone. J Periodontol 2002;73:1141-1148.
24. Goodson JM, Hogan PE, Dunham SL. Clinical responses following periodontal treatment by local drug delivery. J Periodontol 1985;56(Suppl. 11):81-87.
25. Needleman IG, Pandya NV, Smith SR, Foyle DM. The role of antibiotics in the treatment of periodontitis (Part 2-Controlled drug delivery). Eur J Prosthodont Restor Dent 1995;3:111-117.
26. Sotiriou CG, Cheng JW. Beneficial effects of statins in coronary artery disease - Beyond lowering cholesterol. Ann Pharmacother 2000;34:1432-1439.
27. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004;31:671-679.
28. Tobert JA. New developments in lipid-lowering therapy: The role of inhibitors of hydroxymethylglutarylcoenzyme A reductase. Circulation 1987;76:534-538.
29. Song C, Guo Z, Ma Q, et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003;308: 458-462.
30. Baek KH, Lee WY, Oh KW, et al. The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells. J Korean Med Sci 2005;20:438-444.
31. Junqueira JC, Mancini MN, Carvalho YR, Anbinder AL, Balducci I, Rocha RF. Effects of simvastatin on bone regeneration in the mandibles of ovariectomized rats and on blood cholesterol levels. J Oral Sci 2002;44: 117-124.
32. Pytlik M, Janiec W, Misiarz-Myrta M, Gubala I. Effects of simvastatin on the development of osteopenia caused by ovariectomy in rats. Pol J Pharmacol 2003;55:63-71.
33. Tikiz C, Tikiz H, Taneli F, Gümüsxer G, Tüzün C. Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1- year follow-up study. Clin Rheumatol 2005;24:447-452.
34. Todd PA, Goa KL. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 1990;40:583-607.
35. Alam S, Ueki K, Nakagawa K, et al. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: An immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:22-29.
36. Borg E, Gröndahl K, Persson LG, Gröndahl HG. Marginal bone level around implants assessed in digital and film radiographs: In vivo study in the dog. Clin Implant Dent Relat Res 2000;2:10-17.